<DOC>
	<DOCNO>NCT02246517</DOCNO>
	<brief_summary>Important pharmacological agent treatment chronic neuropathic pain ketamine block NMDA receptor . Nitrous oxide , inhalant agent use extensively In anesthesia , also antagonist property NMDA receptor . The investigator hypothesize prolonged treatment N2O alleviate chronic neuropathic pain different cause ( e.g . diabetic neuropathy , post herpetic neuralgia etc . ) .</brief_summary>
	<brief_title>The Effect N2O Chronic Neuropathic Pain Patients</brief_title>
	<detailed_description>Important pharmacological agent treatment chronic neuropathic pain ketamine block NMDA receptor . Nitrous oxide , inhalant agent use extensively In anesthesia , also antagonist property NMDA receptor . The investigator hypothesize prolonged treatment N2O alleviate chronic neuropathic pain different cause ( e.g . diabetic neuropathy , post herpetic neuralgia etc. ) . In order examine theory Will recruit 40 patient age 18-65 suffer chronic neuropathic pain . The patient divide two group half receive treatment N2O half placebo ( pure O2 ) repeat weekly treatment 4 week . At begin session patient ask fill questionnaire regard pain quality severity</detailed_description>
	<mesh_term>Neuralgia</mesh_term>
	<criteria>men woman age 1865 patient suffer chronic neuropathic pain VAS &gt; 40 DN4 score &gt; 4 take pain medication regular basis Did n't get epidural injection pas month sign informed consent form patient suffer chronic lung disease . patient cancer patient heart disease pregnant lactate woman patient suffer depression</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>